Evidence map›Paper›PMID 35298487›Full record

ArticlePloS one2022

Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.

Edward Nicol, Trisha Ramraj, Mbuzeleni Hlongwa, Wisdom Basera, Ngcwalisa Jama, Carl Lombard, Tracy McClinton-Appollis, Darshini Govindasamy, Desiree Pass, Noluntu Funani and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Experiences of adolescent girls and young women of oral PrEP uptake in rural KwaZulu-Natal.African journal of primary health care & family medicine · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Edward NicolBurden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.ORCID 0000-0001-6019-9259
Trisha RamrajHIV Prevention Research Unit, South African Medical Research Council, Cape Town, South Africa.
Mbuzeleni HlongwaBurden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
Wisdom BaseraBurden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
Ngcwalisa JamaBurden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
Carl LombardBiostatistics Unit, South African Medical Research Council, Cape Town, South Africa.ORCID 0000-0002-2136-6533
Tracy McClinton-AppollisHealth System Research Unit, South African Medical Research Council, Cape Town, South Africa.
Darshini GovindasamyHealth System Research Unit, South African Medical Research Council, Cape Town, South Africa.
Desiree PassBurden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
Noluntu FunaniBurden of Disease Research Unit, South African Medical Research Council, Cape Town, South Africa.
Sarah AheronCenters for Disease Control and Prevention, Pretoria, South Africa.ORCID 0000-0001-6116-826X
Ariana Paredes-VincentCenters for Disease Control and Prevention, Pretoria, South Africa.
Jennifer DrummondCenters for Disease Control and Prevention, Pretoria, South Africa.
Mireille CheyipCenters for Disease Control and Prevention, Pretoria, South Africa.
Sibongile DladlaCenters for Disease Control and Prevention, Pretoria, South Africa.
Jason BedfordCenters for Disease Control and Prevention, Pretoria, South Africa.
Cathy MathewsHealth System Research Unit, South African Medical Research Council, Cape Town, South Africa.
South African Medical Research Council · ZAUniversity of Pretoria · ZA

Funding

CDC HHS NU2GGH002093Medical Research Council MR/T040246/1
6 · The paper itself

Abstract

introductionPre-exposure prophylaxis (PrEP) is an effective prevention intervention that can be used to control HIV incidence especially among people who are at increased risk for HIV such as adolescent girls and young women (AGYW) and adolescent boys and young men (ABYM). In South Africa, various approaches of delivering PrEP have been adopted at different service delivery points (facility-based only, school-based only, community-based only and hybrid school-facility and community-facility models) to overcome challenges associated with individual, structural, and health systems related barriers that may hinder access to and uptake of PrEP among these populations. However, little is known about how to optimize PrEP implementation and operational strategies to achieve high sustained uptake of good quality services for AGYW and ABYM. This study aims to identify effective and feasible PrEP models of care for improving PrEP uptake, continuation, and adherence among AGYW and ABYM. METHODS AND ANALYSIS: A sequential explanatory mixed-methods study will be conducted in 22 service delivery points (SDPs) in uMgungundlovu district, KwaZulu-Natal, South Africa. We will recruit 600 HIV negative, sexually active, high risk, AGYW (aged 15-24 years) and ABYM (aged 15-35 years). Enrolled participants will be followed up at 1-, 4- and 7-months to determine continuation and adherence to PrEP. We will conduct two focus group discussions (with 8 participants in each group) across four groups (i. Initiated PrEP within 1 month, ii. Did not initiate PrEP within 1 month, iii. Continued PrEP at 4/7 months and iv. Did not continue PrEP at 4/7 months) and 48 in-depth interviews from each of the four groups (12 per group). Twelve key informant interviews with stakeholders working in HIV programs will also be conducted. Associations between demographic characteristics stratified by PrEP initiation and by various service-delivery models will be assessed using Chi-square/Fishers exact tests or t-test/Mann Whitney test. A general inductive approach will be used to analyze the qualitative data. ETHICS AND DISSEMINATION: The protocol was approved by the South African Medical Research Council Health Research Ethics Committee (EC051-11/2020). Findings from the study will be communicated to the study population and results will be presented to stakeholders and at appropriate local and international conferences. Outputs will also include a policy brief, peer-reviewed journal articles and research capacity building through research degrees.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdolescentBlack PeopleFemaleHumansIncidenceMaleSouth AfricaAnti-HIV Agents

Identifiers

PMID35298487
PMCPMC8929690
OpenAlexW4221102302

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.